Androgen ablative therapy of advanced hormone-dependent prostate carcinoma Clinical Trials

Delta Trials tracks 2 clinical trials for Androgen ablative therapy of advanced hormone-dependent prostate carcinoma in its publicly accessible dataset. Among the listed trials, 1 open for participant enrollment and 1 trial have reached completion. This research is carried out at 178 clinical sites around the world. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.